Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Rio-Vilarino A, Cenigaonandia-Campillo A, Garcia-Bautista A, Mateos-Gomez PA, Schlaepfer MI, Del Puerto-Nevado L, Aguilera O, Garcia-Garcia L, Galeano C, de Miguel I, Serrano-Lopez J, Banos N, Fernandez-Acenero MJ, Lacal JC, Medico E, Garcia-Foncillas J, Cebrian A
Br J Cancer. 2024 May;130(8):1402-1413. doi: 10.1038/s41416-024-02649-z. Epub 2024 Mar 11.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.